We used a systems biology approach to identify functional markers of a tumor-specific immune cell type, TI-Treg, based on the integrative analysis of three sets of CD4+ T cell transcriptome profiles from distinct biological contexts (Fig. 1) [44]. This evidence concerns the gene CD4 and neoplasm.